Stay updated on Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Sign up to get notified when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.

Latest updates to the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page
- CheckyesterdayChange DetectedThe page now shows Revision: v3.6.3, replacing the prior v3.6.2, indicating a minor version update. This update is a software release note and does not affect the study content or visible functionality on the page.SummaryDifference0.0%

- Check8 days agoChange DetectedDifference0.0%

- Check15 days agoNo Change Detected
- Check23 days agoChange DetectedThe page adds a recruitment status line and new navigation/help sections, updates the Intervention/Treatment heading, and includes a revision tag (Revision: v3.6.0) replacing the previous version.SummaryDifference0.4%

- Check30 days agoChange DetectedThe revision tag on the page was updated from v3.5.4 to v3.5.5, indicating a minor update to the page's version. No substantive study details are affected.SummaryDifference0.0%

- Check51 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, signaling a new build or update. This reflects an internal platform or documentation update rather than a change to the study details displayed on the page.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page’s footer “Revision” indicator has been updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

Stay in the know with updates to Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vicriviroc and Pembrolizumab in MSS CRC Clinical Trial page.